戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 912487作成日:2026年10月26日

8-Hydroxyquinoline → (3aR,6aR)-ethyl 1-(4'-(6-oxopyridazin-1(6H)-yl)biphenyl-4-yl)hexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxylate

https://huagongshe.com/reaction/912487

反応式

関与物質

役割名称HCID仕込み量
反応物8-HydroxyquinolineHCID 1923—
反応物Potassium CarbonateHCID 11430—
反応物3(2H)-PyridazinoneHCID 68153—
反応物Ethyl (3ar,6ar)-1-(4'-bromo-1,1'-biphenyl-4-yl)hexahydropyrrolo[3,4-b]pyrrole-5(1h)-carboxylateHCID 67397057—
触媒Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)HCID 24350—
溶媒DimethylformamideHCID 6228—
生成物(3aR,6aR)-ethyl 1-(4'-(6-oxopyridazin-1(6H)-yl)biphenyl-4-yl)hexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxylateHCID 6739652681.9%

反応条件

温度140 °C

反応手順

A mixture of 1.98 g of copper (I) iodide (10.4 mmole, 0.10 eq.), 1.66 g of 8-hydroxyquinoline (11.44 mmole, 0.11 eq.), 4.0 g of potassium carbonate (28.94 mmole, 0.29 eq.) in 18.8 g of dimethylformamide (DMF) was mixed at ambient temperature. The mixture was added to another flask containing 41.6 g of the product of Example 1D (100.16 mmole, 1.00 eq.), 23.6 g of potassium carbonate (170.75 mmole, 1.70 eq.), and 14.4 g of 3(2H)-pyridazinone (149.86 mmole, 1.50 eq.). Additional DMF (226 g) was used to transfer the catalyst slurry. The resulting mixture was deoxygenated then heated to 140° C. for about 18 hours. After cooling to ambient temperature, the mixture was diluted with 567 g of THF and 384 g of 10% NaCl solution. The mixture was filtered to remove excess salts and the aqueous phase was separated and back extracted with an additional 177 g of THF. The combined organic phases were then washed with 10% NaCl solution (3×384 g). The organic phase was concentrated under reduced pressure and MeOH (253 g) was added and the contents were concentrated under reduced pressure. After adding additional MeOH (158 g), the contents were cooled to 0° C., filtered, and washed with cold MeOH. The resulting solids were transferred to a vacuum oven to yield 35.31 g (81.9% yield). Mass Spectroscopy: 431.5 (m.w. 430.5). 1H NMR (400 MHz, DMSO-d6) δ ppm 1.15 (s, 3 H), 1.78-1.88 (m, 1 H), 2.10 (ddd, J=12.49, 6.17, 6.04 Hz, 1H), 3.03 (s, 1 H), 3.24-3.35 (m, 5 H), 3.53 (ddd, J=9.23, 6.86, 6.69 Hz, 2 H), 3.67 (s, 1 H), 4.00 (s, 2 H), 4.22 (s, 1 H), 6.63 (d, J=8.51 Hz, 2 H), 7.07 (dd, J=9.47, 1.51 Hz, 1 H), 7.48 (dd, J=9.47, 3.84 Hz, 1 H), 7.53-7.60 (m, 4 H), 7.68 (d, J=8.64 Hz, 2 H), 8.06 (dd, J=3.84, 1.51 Hz, 1 H). 13C NMR (100 MHz, DMSO-d6) δ ppm 14.79 (CH3), 28.89 (CH2), 47.71 (CH2), 60.24 (CH2), 112.34 (CH), 124.87 (CH), 125.27 (CH), 126.02 (C), 126.89 (CH), 130.05 (CH), 131.69 (CH), 136.87 (CH), 138.78 (C), 139.31 (C), 145.61 (C), 153.53 (C), 158.64 (C).

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US08026240B2
出典データセットuspto-grants-2011_09
ORD IDord-ff578ea522604ea0ae3324d1cd9ef64a
出典メモuspto-grants-2011_09